Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-03-01

Clinical Trial Update: Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing chloroquine in combination with dehydroepiandrosterone sulfate for uncomplicated falciparum malaria has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)
  • Dehydroepiandrosterone sulfate (dehydroepiandrosterone sulfate)

Snippet

Sponsor: Université Victor Segalen Bordeaux 2 | Conditions: Malaria | Phase 3 | Status: SUSPENDED